CRNX icon

Crinetics Pharmaceuticals
CRNX

Overview Fund Activity

122 hedge funds and large institutions have $948M invested in Crinetics Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
+11
Holders Change %
+9.91%
% of All Funds
2.11%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
24
Increased
45
Reduced
28
Closed
13
Calls
$2.51M
Puts
–
Net Calls
+$2.51M
Net Calls Change
-$61K

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
$51.7M
2
PBA
Paradigm Biocapital Advisors
New York
$10.2M
3
BNP Paribas Asset Management
BNP Paribas Asset Management
France
$8.94M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
$7.46M
5
DCM
Driehaus Capital Management
Illinois
$111M

Top Sellers

1
SCM
Suvretta Capital Management
New York
$0
2
Fidelity Investments
Fidelity Investments
Massachusetts
$52.7M
3
PAMP
Polar Asset Management Partners
Ontario, Canada
$0
4
Millennium Management
Millennium Management
New York
$6.32M
5
Nuveen Asset Management
Nuveen Asset Management
Illinois
$5.83M
Name Holding Trade Value Shares
Change 		Shares
Change %
AQR Capital Management
126
AQR Capital Management
Connecticut
– -$189K -10,138 Closed
DCM
127
Dupont Capital Management
Delaware
– -$161K -8,629 Closed
CAPTRUST Financial Advisors
128
CAPTRUST Financial Advisors
North Carolina
– -$22K -1,192 Closed
Simplex Trading
129
Simplex Trading
Illinois
– -$10K -552 Closed
BFEC
130
Benjamin F. Edwards & Company
Missouri
– -$4K -200 Closed
SOW
131
State of Wyoming
Wyoming
– -$1K -70 Closed
2 3 4 5
6